PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 13, 2026Infection and Drug Resistance0 citationsOpen Access

Clinical Risk Factors and Outcomes of Carbapenem-Resistant Pseudomonas aeruginosa Nosocomial Infections in a Tertiary Hospital in China: A Retrospective Study from 2016 to 2023

View Full Paper
XLX LiTZTao ZhangTLTong Liu

Key Points

  • This study aims to identify risk factors for nosocomial CRPA infections and evaluate their impact on in-hospital mortality.
  • Retrospective case-control study at Putuo Hospital from 2016 to 2023
  • Collected data from 208 CRPA infections and a control group of 416 CSPA infections
  • Analyzed clinical characteristics using the hospital information system
  • Performed univariate and multivariate analyses to assess risk factors
  • In-hospital mortality rate for CRPA was 30.3%
  • Significant risk factors included hypoproteinemia, ICU admission, and respiratory disease
  • Previous antibiotic exposure to carbapenems elevated risk
  • Co-infections with Klebsiella pneumoniae and fungi increased infection risk
  • Identified independent risk factors for mortality include cerebrovascular disease and mechanical ventilation

Abstract

Purpose: The global spread of carbapenem-resistant Pseudomonas aeruginosa (CRPA) represents a growing concern for public health, but long-term data from general tertiary hospitals in China are limited. This study aimed to identify risk factors for nosocomial CRPA infection and to evaluate their impact on in-hospital mortality. Methods: A retrospective case-control study of patients with Pseudomonas aeruginosa ( P. aeruginosa ) infections was conducted at Putuo Hospital from January 2016 to December 2023. A total of 208 CRPA clinical isolates were collected in the 8-year study. The control group was randomly selected at a ratio of 1:1 from patients with carbapenem-susceptible P. aeruginosa (CSPA) infection from the same period (within 2 weeks) and department (416 patients). The clinical characteristics of the inpatients were reviewed using the hospital information system. Univariate and multivariate analyses were performed to evaluate the risk factors associated with the development of CRPA infections. Results: The significant risk factors for CRPA infection were hypoproteinemia (OR=4.285, p < 0.001), admission to the intensive care unit (OR=2.143, p = 0.034), respiratory disease (OR=3.412, p < 0.001), nasogastric tube (OR =2.461, p = 0.007), hemoglobin < 90 g/L (OR =2.453, p = 0.004), previous antibiotic exposure to carbapenems (OR =5.580, p < 0.001), and co-infection with Klebsiella pneumoniae (OR=4.318, p < 0.001) and fungi (OR=4.781, p = 0.004). Within CRPA group, the in-hospital mortality rate was 30.3%, and cerebrovascular disease (OR=1.818, p = 0.003), carbapenem exposure (OR=2.625, p = 0.006), and mechanical ventilation (OR=2.157, p = 0.02) were independent risk factors for in-hospital mortality in patients with CRPA infections. Conclusion: Our findings help identify patients at high risk for CRPA infection and underscore the importance of antimicrobial stewardship and infection control measures in hospital settings. Keywords: carbapenem-resistant Pseudomonas aeruginosa , risk factors, nosocomial infection, antimicrobial resistance

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/6a03cb781c527af8f1ecf1dehttps://doi.org/10.2147/idr.s604656
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1P-51. Carbapenem-Resistant Pseudomonas aeruginosa Bloodstream Infections: A Retrospective Case-Control Study2026
  2. 2Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study2024 · 10 citations
  3. 3Clinical distribution and drug resistance of carbapenem-resistant Pseudomonas aeruginosa infection in Eastern China from 2019 to 20242026
  4. 4Enhanced Spread of Carbapenem-Resistant Pseudomonas aeruginosa in ICU Environment During a COVID-19 Upsurge Period in China2026
  5. 5Molecular Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Before the COVID-19 Pandemic: Resistance Profiles and Clonality in a Tertiary-Care Hospital2026 · 2 citations